These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23957979)

  • 1. Efficacy and safety of calcipotriol/betamethasone dipropionate ointment for the treatment of simple onycholysis: an open-label study.
    Park JM; Mun JH; Jwa SW; Song M; Kim HS; Ko HC; Kim BS; Kim MB
    J Am Acad Dermatol; 2013 Sep; 69(3):492-3. PubMed ID: 23957979
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of combined calcipotriol and betamethasone dipropionate ointment in the treatment of vitiligo: an open, uncontrolled trial.
    Xing C; Xu A
    J Drugs Dermatol; 2012 Oct; 11(10):e52-4. PubMed ID: 23135000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy, safety, and cost-effectiveness of all-trans retinoic acid/Clobetasol Propionate Compound Ointment in the treatment of mild to moderate psoriasis vulgaris: A randomized, single-blind, multicenter clinical trial.
    Xia L; Li R; Wang Y; Lin Z; Zheng J; Li X; Lu Q; Zhang J; Jin H; Fu L; Zhang X; Liu Y; Yang S; Xiao F; Gao XH
    Dermatol Ther; 2018 Sep; 31(5):e12632. PubMed ID: 30253049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcipotriol/betamethasone dipropionate ointment compared with tacrolimus ointment for the treatment of erosive pustular dermatosis of the scalp: a split-lesion comparison.
    Pagliarello C; Fabrizi G; Fantini C; Cortelazzi C; Boccaletti V; Annessi G; Zampetti A; Feliciani C; Di Nuzzo S
    Eur J Dermatol; 2015 Apr; 25(2):206-8. PubMed ID: 25786341
    [No Abstract]   [Full Text] [Related]  

  • 5. Taclonex (calcipotriene 0.005% and betamethasone dipropionate 0.064%) ointment.
    Abramovits W; Perlmutter A; Gupta AK
    Skinmed; 2006; 5(3):136-8. PubMed ID: 16687982
    [No Abstract]   [Full Text] [Related]  

  • 6. Topical calcipotriene 0.005% and betamethasone dipropionate 0.064% maintains efficacy of etanercept after step-down dose in patients with moderate-to-severe plaque psoriasis: results of an open label trial.
    Kircik LH
    J Drugs Dermatol; 2011 Aug; 10(8):878-82. PubMed ID: 21818509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined treatment with low-dose cyclosporine and calcipotriol/betamethasone dipropionate ointment for moderate-to-severe plaque psoriasis: a randomized controlled open-label study.
    Vena GA; Galluccio A; Pezza M; Vestita M; Cassano N
    J Dermatolog Treat; 2012 Aug; 23(4):255-60. PubMed ID: 21756153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcipotriene 0.005% and betamethasone dipropionate 0.064% combination topical suspension (Taclonex Scalp).
    Scheinfeld NS
    Skinmed; 2011; 9(3):179-80. PubMed ID: 21675498
    [No Abstract]   [Full Text] [Related]  

  • 9. Pooled safety analysis of calcipotriol plus betamethasone dipropionate gel for the treatment of psoriasis on the body and scalp.
    Kragballe K; van de Kerkhof P
    J Eur Acad Dermatol Venereol; 2014 May; 28 Suppl 2():10-21. PubMed ID: 24684739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.
    Menter A; Abramovits W; Colón LE; Johnson LA; Gottschalk RW
    J Drugs Dermatol; 2009 Jan; 8(1):52-7. PubMed ID: 19180896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of the safety and efficacy of calcipotriol and betamethasone dipropionate scalp formulation in the long-term management of scalp psoriasis.
    Luger TA; Cambazard F; Larsen FG; Bourcier M; Gupta G; Clonier F; Kidson P; Shear NH
    Dermatology; 2008; 217(4):321-8. PubMed ID: 18787325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective assessment of PASI 50 and PASI 75 attainment with a calcipotriol/betamethasone dipropionate ointment.
    Anstey AV; Kragballe K
    Int J Dermatol; 2006 Aug; 45(8):970-5. PubMed ID: 16911387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcipotriol and betamethasone dipropionate (Dovobet, Daivobet): a new formulation for the treatment of psoriasis.
    Poulin Y
    Skin Therapy Lett; 2002 Jun; 7(6):1-3. PubMed ID: 12223976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcipotriol plus betamethasone dipropionate gel compared with its active components in the same vehicle and the vehicle alone in the treatment of psoriasis vulgaris: a randomised, parallel group, double-blind, exploratory study.
    Fleming C; Ganslandt C; Guenther L; Johannesson A; Buckley C; Simon JC; Stegmann H; Vestergaard Tingleff L
    Eur J Dermatol; 2010; 20(4):465-71. PubMed ID: 20413372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short- and long-term safety assessment of a two-compound ointment containing calcipotriene/betamethasone dipropionate (Taclonex/Daivobet/Dovobet ointment): hypothalamic-pituitary-adrenal axis function in patients with psoriasis vulgaris.
    Fleming C; Ganslandt C; Leese GP
    J Drugs Dermatol; 2010 Aug; 9(8):969-74. PubMed ID: 20684147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once-daily application of calcipotriene 0.005%-betamethasone dipropionate 0.064% ointment for repigmentation of facial vitiligo.
    Newman MD; Silverberg NB
    Cutis; 2011 Nov; 88(5):256-9. PubMed ID: 22272490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcipotriol plus betamethasone dipropionate gel compared with tacalcitol ointment and the gel vehicle alone in patients with psoriasis vulgaris: a randomized, controlled clinical trial.
    Langley RG; Gupta A; Papp K; Wexler D; Østerdal ML; Curčić D
    Dermatology; 2011; 222(2):148-56. PubMed ID: 21293107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcipotriol/betamethasone dipropionate ointment in mild-to-moderate paediatric psoriasis: long-term daily clinical practice data in a prospective cohort.
    van Geel MJ; Mul K; Oostveen AM; van de Kerkhof PC; de Jong EM; Seyger MM
    Br J Dermatol; 2014 Aug; 171(2):363-9. PubMed ID: 24593129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.
    Kragballe K; Noerrelund KL; Lui H; Ortonne JP; Wozel G; Uurasmaa T; Fleming C; Estebaranz JL; Hanssen LI; Persson LM
    Br J Dermatol; 2004 Jun; 150(6):1167-73. PubMed ID: 15214905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a psoriasis plaque test in the development of a gel formulation of calcipotriol and betamethasone dipropionate for scalp psoriasis.
    Queille-Roussel C; Hoffmann V; Enevold A; Ganslandt C
    J Dermatolog Treat; 2013 Aug; 24(4):250-4. PubMed ID: 22103604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.